Recently, a number of studies have reported the role of MDM2 SNP309 polymorphism in gastric cancer risk, but the results are inconclusive, partially because of the possible small effect of the polymorphism on gastric cancer and the relatively small size in each of the published studies. Here, MDM2 is linked to gastric cancer.